FEBS Open Bio Editorial Office, Cambridge, UK.
Department of Medical Biotechnology and Translational Medicine, University of Milano, Italy.
FEBS Open Bio. 2023 Sep;13(9):1544-1547. doi: 10.1002/2211-5463.13689. Epub 2023 Aug 22.
Sandro Sonnino is one of the founding members of the Editorial Board of FEBS Open Bio, having joined in 2011. He is also a member of the Editorial Board of FEBS Letters and is the Editor-in-Chief of Glycoconjugate Journal. He is full professor of biochemistry in the School of Medicine at the University of Milan, where he was also formerly coordinator of the Interdisciplinary Laboratory of Advanced Technology (LITA) and Director of the Department of Medical Chemistry, Biochemistry, and Biotechnology. His research is focused on the metabolism and biochemical properties of gangliosides and glycosphingolipids, and their role in cell signaling and the nervous system. He is a guest editor of this special "In the Limelight" issue on glycosphingolipids in disease, which features multiple Reviews and an original research article related to this field. In this interview, Sandro Sonnino discusses the ongoing importance of research on glycosphingolipids and his personal career journey.
桑德罗·索尼诺(Sandro Sonnino)是 FEBS Open Bio 编委会的创始成员之一,于 2011 年加入。他还是 FEBS Letters 编委会的成员,同时担任 Glycoconjugate Journal 的主编。他是米兰大学医学院生物化学专业的全职教授,曾任跨学科先进技术实验室(LITA)的协调员和医学化学、生物化学和生物技术系主任。他的研究集中在神经酰胺和糖脂的代谢和生化特性及其在细胞信号转导和神经系统中的作用。他是本期“聚光灯下”关于疾病中糖脂的特刊的客座编辑,该特刊收录了多篇与该领域相关的综述和原创研究文章。在本次采访中,桑德罗·索尼诺讨论了糖脂研究的持续重要性以及他个人的职业发展历程。